Publications
Filters: First Letter Of Title is M [Clear All Filters]
“Mass drug administrations with dihydroartemisinin-piperaquine and single low dose primaquine to eliminate Plasmodium falciparum have only a transient impact on Plasmodium vivax: Findings from randomised controlled trials”, PLoS One, vol. 15, no. 2, p. e0228190, 2020.
, “A modular framework for the development of targeted Covid-19 blood transcript profiling panels”, Journal of Translational Medicine, vol. 18, no. 1, p. 291, 2020.
, “Molecular epidemiology of resistance to antimalarial drugs in the Greater Mekong subregion: an observational study”, Lancet Infect Dis, 2020.
, “Multiplex Human Malaria Array: Quantifying Antigens for Malaria Rapid Diagnostics”, Am J Trop Med Hyg, vol. 102, no. 6, pp. 1366-1369, 2020.
, “Maternal Hepatitis B Infection Burden, Comorbidity and Pregnancy Outcome in a Low-Income Population on the Myanmar-Thailand Border: A Retrospective Cohort Study”, J Pregnancy, vol. 2019, p. 8435019, 2019.
, “Molecular characterization and mapping of glucose-6-phosphate dehydrogenase (G6PD) mutations in the Greater Mekong Subregion”, Malar J, vol. 18, no. 1, p. 20, 2019.
, “Malaria”, The Lancet, vol. 391, pp. 1608-1621, 2018.
, “Melioidosis in Myanmar”, Trop Med Infect Dis, vol. 3, no. 1, 2018.
, “Migrant perinatal depression study: a prospective cohort study of perinatal depression on the Thai-Myanmar border”, BMJ Open, vol. 8, no. 1, p. e017129, 2018.
, “Mediation of the effect of malaria in pregnancy on stillbirth and neonatal death in an area of low transmission: observational data analysis”, BMC Med, vol. 15, no. 1, p. 98, 2017.
, “Methodology of assessment and reporting of safety in anti-malarial treatment efficacy studies of uncomplicated falciparum malaria in pregnancy: a systematic literature review”, Malaria Journal, vol. 16, no. 1, p. 491, 2017.
, “Methods for the field evaluation of quantitative G6PD diagnostics: a review”, Malaria Journal, vol. 16, no. 1, p. 361, 2017.
, “Migrant tuberculosis patient needs and health system response along the Thailand-Myanmar border”, Health Policy Plan, vol. 32, no. 8, pp. 1212-1219, 2017.
, “Migration histories of multidrug-resistant tuberculosis patients from the Thailand-Myanmar border, 2012-2014”, Int J Tuberc Lung Dis, vol. 21, no. 7, pp. 753-758, 2017.
, “A multi-level spatial analysis of clinical malaria and subclinical Plasmodium infections in Pailin Province, Cambodia”, Heliyon, vol. 3, no. 11, p. e00447, 2017.
, “Management of relapsing Plasmodium vivax malaria”, Expert Rev Anti Infect Ther, 2016.
, “Maternal suicide risk among refugees and migrants”, Int J Gynaecol Obstet, 2016.
, “Maternal-foetal transfer of Plasmodium falciparum and Plasmodium vivax antibodies in a low transmission setting”, Sci Rep, vol. 6, p. 20859, 2016.
, “Microgeographically diverse Plasmodium vivax populations at the Thai-Myanmar border”, Infect Genet Evol, vol. 45, pp. 341-346, 2016.
, “Migrant and Refugee Patient Perspectives on Travel and Tuberculosis along the Thailand-Myanmar Border: A Qualitative Study”, PLoS One, vol. 11, no. 8, p. e0160222, 2016.
, , “Malaria ecology along the Thailand-Myanmar border”, Malar J, vol. 14, no. 1, p. 388, 2015.
, “Methylene blue inhibits the asexual development of vivax malaria parasites from a region of increasing chloroquine resistance”, J Antimicrob Chemother, vol. 70, no. 1, pp. 124-9, 2015.
, “Microgeography and molecular epidemiology of malaria at the Thailand-Myanmar border in the malaria pre-elimination phase”, Malar J, vol. 14, p. 198, 2015.
, “Modeling the dynamics of Plasmodium vivax infection and hypnozoite reactivation in vivo”, PLoS Negl Trop Dis, vol. 9, no. 3, p. e0003595, 2015.
, “Molecular Markers and In Vitro Susceptibility to Doxycycline in Plasmodium falciparum Isolates from Thailand”, Antimicrob Agents Chemother, 2015.
, “A morphometric and histological study of placental malaria shows significant changes to villous architecture in both Plasmodium falciparum and Plasmodium vivax infection”, Malar J, vol. 13, no. 1, p. 4, 2014.
, “Motivations and perceptions of community advisory boards in the ethics of medical research: the case of the Thai-Myanmar border”, BMC Medical Ethics, vol. 15, no. 1, p. 12, 2014.
, “Made in Europe: will artemisinin resistance emerge in French Guiana?”, Malar J, vol. 12, p. 152, 2013.
, “Malaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999-2011: an observational study”, PLoS Med, vol. 10, no. 3, p. e1001398, 2013.
, “Malaria in the post-partum period; a prospective cohort study”, PLoS ONE, vol. 8, no. 3, p. e57890, 2013.
, “Microsatellite genotyping of Plasmodium vivax infections and their relapses in pregnant and non-pregnant patients on the Thai-Myanmar border”, Malar J, vol. 12, p. 275, 2013.
, “Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia”, Nat Genet, vol. 45, no. 6, pp. 648-55, 2013.
, “A Major Genome Region Underlying Artemisinin Resistance in Malaria”, Science, vol. 336, no. 6077, pp. 79-82, 2012.
, “Malaria in pregnancy in the Asia-Pacific region”, The Lancet Infectious Diseases, vol. 12, no. 1, pp. 75-88, 2012.
, “Micronutrient status in lactating mothers before and after introduction of fortified flour: cross-sectional surveys in Maela refugee camp”, Eur J Nutr, vol. 51, no. 4, pp. 425-34, 2012.
, “Malaria in pregnancy: the difficulties in measuring birthweight”, BJOG, vol. 118, no. 6, pp. 671-678, 2011.
, “Methotrexate is highly potent against pyrimethamine-resistant Plasmodium vivax”, J Infect Dis, vol. 203, no. 2, pp. 207-10, 2011.
, “Malaria in children”, Lancet, vol. 375, no. 9724, pp. 1468-81, 2010.
, “[Malaria in pregnancy: a therapeutic dilemma]”, Med Sci (Paris), vol. 25, no. 10, pp. 867-9, 2009.
, “MUAC and BMI: usefulness in pregnancy among refugee and migrant population along the Thai-Myanmar border”, in 19th International Congress of Nutrition, Bangkok, Thailand, 2009, vol. 55, p. 215.
, “Multiple displacement amplification for malaria parasite DNA”, J Parasitol, vol. 95, no. 1, pp. 253-5, 2009.
, “Major pitfalls in the measurement of artemisinin derivatives in plasma in clinical studies”, J Chromatogr B Analyt Technol Biomed Life Sci, vol. 876, no. 1, pp. 54-60, 2008.
, “Malaria”, Travel Med Infect Dis, vol. 4, no. 3-4. pp. 159-173, 2006.
, “Manslaughter by fake artesunate in Asia--will Africa be next?”, PLoS Med, vol. 3, no. 6, p. e197, 2006.
, “Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria”, Clin Infect Dis, vol. 42, no. 11, pp. 1570-7, 2006.
, “[Malaria control in Plasmodium falciparum resistant to multi-therapy a field opinion]”, Med Trop (Mars), vol. 65, no. 1, pp. 91-2, 2005.
, “Malaria misconceptions”, Lancet, vol. 365, no. 9460, p. 653, 2005.
, “Malaria and the pregnant traveller”, Travel Medicine and Infectious Disease, vol. 2, no. 3-4, pp. 127-142, 2004.
, “Malaria in pregnancy and the endemicity spectrum: what can we learn?”, Trends in Parasitology, vol. 20, no. 9, pp. 425-432, 2004.
, “Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number”, Lancet, vol. 364, no. 9432, pp. 438-47, 2004.
, “Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development”, Lancet Infectious diseases, vol. 2, no. 9, p. 564., 2002.
, “Malaria epidemic in Burundi”, Lancet, vol. 357, no. 9261, pp. 1046-7., 2001.
, “Malaria epidemiology and control in refugee camps and complex emergencies”, Annals of Tropical Medicine and Parasitology, vol. 95, no. 8, pp. 741-54., 2001.
, “Menorrhagia caused by dengue fever”, Australia and New Zealand Journal of Obstetrics and Gynaecology, vol. 40, no. 3, pp. 354-5., 2000.
, “Microsatellite markers reveal a spectrum of population structures in the malaria parasite plasmodium falciparum”, Molecular Biology and Evolution, vol. 17, no. 10, pp. 1467-82, 2000.
, “Meet my uncle”, Lancet, vol. 353, no. 9150, p. 414., 1999.
, “Modes d'action et caracteristiques pharmacologiques des antipaludiques”, Medecine et Maladies Infectieuses, vol. 29, Supplement 3, pp. S307-S315, 1999.
, “Maternal antibodies block malaria”, NATURE, vol. 395, no. 6705. pp. 851-2, 1998.
, “Malaria: still no vaccine and very few drugs”, Current Opinion in Infectious Diseases, vol. 9, no. 6, pp. 429-434, 1996.
, “Mefloquine in infants and young children”, Annals of Tropical Paediatrics, vol. 16, no. 4, pp. 281-6, 1996.
, “Mefloquine treatment of acute falciparum malaria: a prospective study of non-serious adverse effects in 3673 patients”, Bulletin of the World Health Organization, vol. 73, no. 5, pp. 631-42, 1995.
, “Mefloquine prophylaxis prevents malaria during pregnancy: a double- blind, placebo-controlled study”, Journal of Infectious Diseases, vol. 169, no. 3, pp. 595-603, 1994.
, “Mefloquine prophylaxis”, Lancet, vol. 342, p. 551, 1993.
, “Malaria during pregnancy in an area of unstable endemicity”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 85, no. 4, pp. 424-9, 1991.
, “Mefloquine for multidrug-resistant malaria”, Lancet, vol. 338. p. 1268, 1991.
, “Mefloquine pharmacokinetics and resistance in children with acute falciparum malaria”, British Journal of Clinical Pharmacology, vol. 31, no. 5, pp. 556-9, 1991.
, “Mefloquine-resistant falciparum malaria on the Thai-Burmese border”, Lancet, vol. 337, no. 8750, pp. 1140-3, 1991.
, “Mefloquine antimalarial prophylaxis in pregnancy: dose finding and pharmacokinetic study”, British Journal of Clinical Pharmacology, vol. 30, no. 1. pp. 79-85, 1990.
, “Malaria on the Thai-Burmese border: treatment of 5192 patients with mefloquine-sulfadoxine-pyrimethamine”, Bulletin of the World Health Organization, vol. 65, no. 6. pp. 891-6, 1987.
,